• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Drug-Eluting Balloons Are Coming, But Are We Ready?

作者信息

Spaulding Christian

机构信息

Cardiology Department, European Hospital Georges Pompidou, Assistance Publique Hôpitaux de Paris, Paris University and Sudden Cardiac Death Expert Center, Paris, France.

出版信息

Cardiovasc Revasc Med. 2022 Feb;35:83-84. doi: 10.1016/j.carrev.2021.11.020. Epub 2021 Nov 20.

DOI:10.1016/j.carrev.2021.11.020
PMID:34824039
Abstract
摘要

相似文献

1
Drug-Eluting Balloons Are Coming, But Are We Ready?药物洗脱球囊即将问世，但我们准备好了吗？
Cardiovasc Revasc Med. 2022 Feb;35:83-84. doi: 10.1016/j.carrev.2021.11.020. Epub 2021 Nov 20.
2
Long-Term Outcomes Following Drug-Eluting Balloons Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis (DEB-Dragon-Registry).药物涂层球囊与药物洗脱支架治疗支架内再狭窄的长期结果（DEB-Dragon-Registry）。
Circ Cardiovasc Interv. 2021 Sep;14(9):e010868. doi: 10.1161/CIRCINTERVENTIONS.121.010868. Epub 2021 Sep 3.
3
3-Year Clinical Follow-Up of the RIBS IV Clinical Trial: A Prospective Randomized Study of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis in Coronary Arteries Previously Treated With Drug-Eluting Stents.3 年 RIBS IV 临床试验临床随访：药物洗脱球囊与依维莫司洗脱支架治疗药物洗脱支架治疗后冠状动脉支架内再狭窄患者的前瞻性随机研究。
JACC Cardiovasc Interv. 2018 May 28;11(10):981-991. doi: 10.1016/j.jcin.2018.02.037.
4
Long-Term Results of Everolimus-Eluting Stents Versus Drug-Eluting Balloons in Patients With Bare-Metal In-Stent Restenosis: 3-Year Follow-Up of the RIBS V Clinical Trial.载药支架与药物球囊治疗金属裸支架内再狭窄的长期疗效：RIBS V 临床试验 3 年随访结果。
JACC Cardiovasc Interv. 2016 Jun 27;9(12):1246-1255. doi: 10.1016/j.jcin.2016.03.037. Epub 2016 Jun 20.
5
"Back to the future: Beta radiation to treat recurrent in-stent restenosis".“回到未来：β射线治疗支架内再狭窄复发”。
Catheter Cardiovasc Interv. 2021 Jan 1;97(1):47. doi: 10.1002/ccd.29448.
6
Second-generation drug-eluting stents versus drug-coated balloons for the treatment of coronary in-stent restenosis: A systematic review and meta-analysis.第二代药物洗脱支架与药物涂层球囊治疗冠状动脉支架内再狭窄的系统评价和荟萃分析
Catheter Cardiovasc Interv. 2018 Aug 1;92(2):285-299. doi: 10.1002/ccd.27359. Epub 2017 Oct 10.
7
Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.药物洗脱球囊成功治疗的分叉病变中药物洗脱支架的支架内再狭窄复发
Cardiovasc Revasc Med. 2013 Mar-Apr;14(2):106-8. doi: 10.1016/j.carrev.2012.10.009. Epub 2012 Nov 26.
8
Kissing drug eluting balloons for in-stent restenosis complicating bifurcations treated with drug-eluting stents.药物洗脱球囊治疗药物洗脱支架治疗分叉病变后支架内再狭窄。
Catheter Cardiovasc Interv. 2012 Feb 15;79(3):392-6. doi: 10.1002/ccd.23256. Epub 2012 Jan 10.
9
The efficacy and safety of drug-eluting balloons for the treatment of in-stent restenosis as compared with drug-eluting stents and with conventional balloon angioplasty.与药物洗脱支架及传统球囊血管成形术相比，药物洗脱球囊治疗支架内再狭窄的疗效和安全性。
Korean J Intern Med. 2016 May;31(3):501-6. doi: 10.3904/kjim.2014.189. Epub 2015 Dec 21.
10
Drug-eluting stents and drug-eluting balloons are the best strategies to treat coronary in-stent restenosis.
Evid Based Med. 2016 Jun;21(3):90. doi: 10.1136/ebmed-2015-110372. Epub 2016 Feb 10.

引用本文的文献

1
Sulfasalazine induces autophagy inhibiting neointimal hyperplasia following carotid artery injuries in mice.柳氮磺胺吡啶通过诱导自噬抑制小鼠颈动脉损伤后的内膜增生。
Front Bioeng Biotechnol. 2023 May 23;11:1199785. doi: 10.3389/fbioe.2023.1199785. eCollection 2023.
2
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia.阿魏酸接枝聚乳酸-乙醇酸共聚物作为设计氟伐他汀洗脱纳米粒子用于预防内膜增生的新型材料。
Mol Pharm. 2022 Nov 7;19(11):4333-4344. doi: 10.1021/acs.molpharmaceut.2c00693. Epub 2022 Oct 17.